Research programme: mRNA therapeutics - Chiesi Farmaceutici/Moderna
Latest Information Update: 18 Sep 2020
At a glance
- Originator Chiesi Farmaceutici; Moderna Therapeutics
- Class RNA
- Mechanism of Action Protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Pulmonary arterial hypertension